Upcoming treatments for morphea.

Immun Inflamm Dis · 2021 · PMC8589364 · PMID 34272836

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

116 , 117 In early dcSSc, abatacept failed to improve skin score, though it showed a trend toward significance as well as manageable AEs. 118 In contrast, numerous published cases exist for the use of abatacept in patients with morphea and show promise for future potential large‐scale trials. 119 , 120 , 121 A retrospective compilation of eight cases of juvenile morphea s

also in 53,322 other papers

a trend toward significanceno p-value reported

116 , 117 In early dcSSc, abatacept failed to improve skin score, though it showed a trend toward significance as well as manageable AEs. 118 In contrast, numerous published cases exist for the use of abatacept in patients with morphea and show promise for future potential large‐scale trials. 119 , 120 , 121 A retrospective compilation of eight cases of juvenile morphea showed no progression

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.